The Gross Margin of G1 Therapeutics Inc (GTHX) is
91.28%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date |
Value |
| 2023-12-31 |
91.28%
|
| 2022-12-31 |
92.69%
|
| 2021-12-31 |
93.58%
|
| Ticker |
Name |
Value |
|
CLNN
|
Clene Inc
|
78.50%
|
|
DTIL
|
Precision Biosciences, Inc
|
7775.20%
|
|
GILD
|
Gilead Sciences, Inc.
|
78.84%
|
|
KDNY
|
Chinook Therapeutics Inc
|
7775.20%
|
|
TCRR
|
TCR2 Therapeutics Inc
|
7775.20%
|
|
ABBV
|
AbbVie Inc.
|
71.62%
|
|
AMGN
|
Amgen Inc
|
70.78%
|
|
BDTX
|
Black Diamond Therapeutics Inc
|
7775.20%
|
|
HARP
|
Harpoon Therapeutics Inc
|
7775.20%
|
|
TSHA
|
Taysha Gene Therapies, Inc.
|
7775.20%
|
|
950220.KQ
|
Neoimmunetech Inc
|
7775.20%
|
|
MRNA
|
Moderna, Inc.
|
70.32%
|
|
ORIC
|
ORIC Pharmaceuticals, Inc.
|
7775.20%
|
|
VXRT
|
Vaxart Inc
|
100.00%
|
|
ADAP
|
Adaptimmune Therapeutics PLC
|
99.96%
|
|
ARCT
|
Arcturus Therapeutics Holdings Inc
|
7775.20%
|
|
AVXL
|
Anavex Life Sciences Corp
|
7775.20%
|
|
CMRX
|
Chimerix Inc
|
100.00%
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
86.24%
|
|
950160.KQ
|
Kolon TissueGene Inc
|
13.28%
|
|
IDYA
|
IDEAYA Biosciences, Inc.
|
7775.20%
|
|
MTEM
|
Molecular Templates Inc
|
7775.20%
|
|
EPZM
|
Epizyme Inc
|
71.95%
|
|
MRUS
|
Merus NV
|
7775.20%
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
86.56%
|
|
SGTX
|
Sigilon Therapeutics Inc
|
7775.20%
|
|
INBX
|
Inhibrx Biosciences Inc
|
7775.20%
|
|
DYN
|
Dyne Therapeutics, Inc.
|
7775.20%
|
|
KALV
|
KalVista Pharmaceuticals, Inc.
|
93.72%
|
|
KPTI
|
Karyopharm Therapeutics Inc.
|
95.93%
|
|
BTAI
|
BioXcel Therapeutics Inc
|
74.45%
|
|
ADVM
|
Adverum Biotechnologies Inc
|
7775.20%
|
|
AFMD
|
Affimed NV
|
83.70%
|
|
ALGS
|
Aligos Therapeutics, Inc.
|
7775.20%
|
|
PRTA
|
Prothena Corporation PLC
|
7775.20%
|
|
950200.KQ
|
Psomagen Inc
|
24.48%
|